Analytical Data
-
Gene name
PSG3
- Application
-
Alternative Names
PSG3;Pregnancy-specific beta-1-glycoProtein 3
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q16557
-
Expression Region
35-428aa
-
AA Sequence
QVTIEA EPTKVSKGKD VLLLVHNLPQ NLAGYIWYKG QMKDLYHYIT SYVVDGQIII YGPAYSGRET VYSNASLLIQ NVTREDAGSY TLHIVKRGDG TRGETGHFTF TLYLETPKPS ISSSNLYPRE DMEAVSLTCD PETPDASYLW WMNGQSLPMT HSLQLSKNKR TLFLFGVTKY TAGPYECEIR NPVSASRSDP VTLNLLPKLP KPYITINNLN PRENKDVLAF TCEPKSENYT YIWWLNGQSL PVSPRVKRPI ENRILILPSV TRNETGPYQC EIQDRYGGIR SYPVTLNVLY GPDLPRIYPS FTYYHSGENL YLSCFADSNP PAEYSWTING KFQLSGQKLF IPQITTKHSG LYACSVRNSA TGMESSKSMT VKVSAPSGTG HLPGLNPL
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PSG3, or Pregnancy-Specific Glycoprotein 3, is a member of the pregnancy-specific glycoprotein family, which plays essential roles in various physiological processes during pregnancy. This family of proteins is predominantly produced by trophoblast cells and is secreted into maternal circulation, where its levels can influence maternal-fetal interactions and immune modulation. Research on PSG3 has gained attention due to its potential implications in pregnancy-related disorders and its involvement in the regulation of immune responses at the maternal-fetal interface. Elevated or aberrant levels of PSG3 have been associated with conditions such as preeclampsia, recurrent pregnancy loss, and intrauterine growth restriction, making it a critical biomarker for monitoring pregnancy health. Furthermore, studies have explored the potential role of PSG3 in promoting trophoblast invasion and survival, which are crucial for successful implantation and placental development. Understanding the functional mechanisms of PSG3 could offer insights into its contributions to pregnancy maintenance and the pathophysiology of pregnancy complications. This underscores the importance of ongoing research into PSG3, aiming to elucidate its molecular functions and potential therapeutic applications for improving pregnancy outcomes and addressing maternal-fetal health challenges.











